Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Leukemia 18Leukemia, Myeloid, Acute 12Myelodysplastic Syndromes 10Lymphoma 10Burkitt Lymphoma 8Graft vs Host Disease 7Lymphoma, Mantle-Cell 6Lymphoma, Large B-Cell, Diffuse 6Leukemia, Myeloid, Accelerated Phase 6Leukemia, Lymphocytic, Chronic, B-Cell 6Blast Crisis 6Recurrence 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Pdgfra-Associated Chronic Eosinophilic Leukemia 5Myeloproliferative Disorders 5Myelodysplastic-Myeloproliferative Diseases 5Lymphoma, Non-Hodgkin 5Leukemia, Neutrophilic, Chronic 5Congenital Abnormalities 5Thrombocythemia, Essential 4Primary Myelofibrosis 4Polycythemia Vera 4Lymphoma, Follicular 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Biphenotypic, Acute 4Hodgkin Disease 4Hematologic Neoplasms 4Neoplasms, Plasma Cell 3

Interventions

Radiotherapy 3Cisplatin 2glucarpidase 1apraglutide 1Quercetin 1Methotrexate 1Leucovorin 1Fibroblast Growth Factor 7 1Curcumin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Mucositis × Methotrexate × Clear all
NCT00727831 2014-01-27

Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

University College, London

Phase 1/2 Completed
4 enrolled
LymphoidOther

Lymphoma, Lymphoma, Large B-Cell, Diffuse, Neurotoxicity Syndromes, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡